T. Rowe Price Associates’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-27,677
| Closed | -$266K | – | 3097 |
|
|
2024
Q4 | $266K | Buy |
27,677
+5,491
| +25% | +$52.8K | ﹤0.01% | 2554 |
|
|
2024
Q3 | $64K | Buy |
22,186
+715
| +3% | +$2.06K | ﹤0.01% | 2897 |
|
|
2024
Q2 | $63K | Buy |
21,471
+2,654
| +14% | +$7.79K | ﹤0.01% | 2829 |
|
|
2024
Q1 | $61K | Buy |
18,817
+2,280
| +14% | +$7.39K | ﹤0.01% | 2851 |
|
|
2023
Q4 | $56K | Buy |
16,537
+2,706
| +20% | +$9.16K | ﹤0.01% | 2793 |
|
|
2023
Q3 | $33K | Hold |
13,831
| – | – | ﹤0.01% | 2820 |
|
|
2023
Q2 | $25K | Buy |
+13,831
| New | +$25K | ﹤0.01% | 2853 |
|